IndiaInfoline » Markets » GLENMARK

Glenmark Pharmaceuticals Ltd - Share Price

GLENMARK

Open

511.00

Prev. Close

508.10

Turnover (lac.)

4,394

Day's High

511.00

Day's Low

501.00

52 Week's High

690.95

52 Week's Low

442.05

Book Value

542

Face Value

1

Mkt Cap (Cr.)

14,210

P/E

8.67

EPS

58.07

Divi. Yield

0.5

Glenmark Pharmaceuticals LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Glenmark Pharmaceuticals LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

No Records found

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Glenmark Pharmaceuticals LtdSummary & Reports

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in var... More

Registered Office

B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai, Maharashtra,400026

Tell. : +91-22-40189999
Website : http://www.glenmarkpharma.com
Email : complianceofficer@glenmarkpharma.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

Latest Release by glenmark-pharmaceuticals-ltd-share-price

View

- <

Reco. Price

Sep 21,2021 10:05 AM

Target Price

Target Returns:

0.00%

Result Express

Glenmark Pharmaceuticals Ltd's Q2FY19 consolidated net profit rises 15.27% yoy to Rs246.82cr : Beats Estimates

Sep 28, 2021 07:54 AM

The company’s consolidated revenue stood at Rs2,581.33cr, up 14.39% yoy and 19.2% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    AGM

    Exp. Date

    24 Sep 2021

    Annc. Date

    24 Aug 2021

    AGM 24/09/2021... More

  • Purpose

    Dividend

    Annc. Date

    28 May 2021

    Effective. Date

    08 Sep 2021

    Divi. Type

    Final

    Divi.(%)

    250

    Divi. Amt.

    2.5

    Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meet... More

  • Purpose

    Board Meeting

    Exp. Date

    13 Aug 2021

    Annc. Date

    05 Aug 2021

    Quarterly ResultsGLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Dire... More